MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/pmrj.13051

Медицинская библиотека · PM & R : the journal of injury, function, and rehabilitation · 2023

Autonomic dysreflexia: Current pharmacologic management.

Solinsky Ryan

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

BACKGROUND

Autonomic dysreflexia (AD) is a frequent complication of spinal cord injury (SCI), though current clinical practice patterns for medication management of this condition are unknown. Correspondingly, it is unclear if national differences in practice patterns exist.

OBJECTIVE

To determine trends in current pharmacologic management of AD throughout the Americas.

DESIGN

International survey of current physician practice patterns.

SETTING

Academic medical center.

PARTICIPANTS

Sixty physicians managing patients with SCI and prescribing medications to manage AD.

INTERVENTIONS: Not applicable.

MAIN OUTCOME MEASURES: Presence of a formal pharmacologic AD management protocol, first- and second-line medications, patient characteristics influencing pharmacologic management.

RESULTS

The majority of physicians (69%) had a formal AD management protocol for inpatient care, with nitroglycerin ointment (82%) being the most common first-line medication. Strong national differences existed regarding the use of nitroglycerin ointment, with 98% of U.S.-based physicians using this as first-line medication and 0% of physicians in Canada or Latin America using this due to recent lack of medication availability. Only 67% of physicians had a preferred second-line medication, with preferences split between hydralazine (48%) and nifedipine (28%). A systolic blood pressure threshold for pharmacologic management was used by 56% of physicians, wheres 26% considered neurological level of injury in decisions to use medications for AD. Heart rate was used by only 5% of physicians in their decision to manage AD with medications.

CONCLUSIONS

As of 2023, U.S.-based physicians caring for individuals with SCI largely have formal inpatient protocols in place for medication management of AD, with nearly all relying on nitroglycerin ointment as their first-line medication. In areas outside of the United States where nitroglycerin ointment is unavailable, pharmacologic practice patterns significantly differ.

Для цитирования: Solinsky Ryan. Autonomic dysreflexia: Current pharmacologic management.. PM & R : the journal of injury, function, and rehabilitation. 2023. DOI: 10.1002/pmrj.13051.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.